Eden Files NRC Permit for U.S. Isotope Production
ALBUQUERQUE, N.M., May 5, 2026 Eden Radioisotopes, LLC has filed a Construction Permit Application with the U.S. Nuclear Regulatory...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ALBUQUERQUE, N.M., May 5, 2026 Eden Radioisotopes, LLC has filed a Construction Permit Application with the U.S. Nuclear Regulatory...
ATLANTA, Georgia, USA, April 28, 2026 PharmaLogic Holdings Corp., a leading contract development and manufacturing organization (CDMO) specializing in...
MELBOURNE, AUSTRALIA & INDIANAPOLIS, UNITED STATES — February 18, 2026 Telix Pharmaceuticals has submitted a European Marketing Authorization Application...
SYDNEY, Australia, Feb. 16, 2026 — Clarity Pharmaceuticals announced new clinical data from the Co-PSMA Investigator-Initiated Trial demonstrating that...
LONDON, UK, Feb. 12, 2026 — Serac Healthcare announced that the U.S. Food and Drug Administration has granted Fast...
Louvain-La-Neuve, Belgium, December 19, 2025 — IBA (Ion Beam Applications S.A.), a global leader in particle accelerator technology and...
